Maduck Sean sold $1.5M of CORT
Maduck Sean (See Remarks) sold 21,069 shares of CORCEPT THERAPEUTICS INC (CORT) at $70.11 ($1.48M total) on 2026-06-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale amount and post-transaction holdings are new datapoints, but the 10b5-1 pre-arranged nature typically limits inference about near-term fundamentals.
Market read
Primarily a sentiment/positioning signal; not a standalone fundamental catalyst.
What to watch
The filing date may lag the sale date; traders should not over-weight the disclosure versus any concurrent fundamental headlines.
Background
The article is an SEC Form 4 insider transaction disclosure (officer/direct holdings) for Corcept Therapeutics.
Ticker impact
Corcept Therapeutics insider Maduck Sean sold $1.48M of CORT shares via an open-market transaction under a 10b5-1 plan.
Low near-term impact; any reaction likely fades unless accompanied by unusual volume or other negative company news.
Form 4 shows a scheduled 10b5-1 sale by an officer, which reduces interpretability as a new negative view, but still can affect short-term sentiment.
Market effects
Minimal; this is company-specific insider activity with no stated sector/regulatory catalyst.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can coincide with periods of reduced confidence; monitor for additional Form 4 activity beyond scheduled plans.
Key entities
- issuerCORCEPT THERAPEUTICS INC
Subject of the SEC Form 4 insider sale disclosure.
- insiderMaduck Sean
Officer who sold 21,069 shares of CORT for ~$1.48M under a 10b5-1 plan.
